Vulvar Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology

作者：Koh Wui Jin^*; Greer Benjamin E; Abu Rustum Nadeem R; Campos Susana M; Cho Kathleen R; Chon Hye Sook; Chu Christina; Cohn David; Crispens Marta Ann; Dizon Don S; Dorigo Oliver; Eifel Patricia J; Fisher Christine M; Frederick Peter; Gaffney David K; Han Ernest; Higgins Susan; Huh Warner K; Lurain John R III; Mariani Andrea; Mutch David; Nagel Christa; Nekhlyudov Larissa; Fader Amanda Nickles; Remmenga Steven W; Reynolds R Kevin; Tillmanns Todd

来源：Journal of the National Comprehensive Cancer Network, 2017, 15(1): 92-120.

DOI：10.6004/jnccn.2017.0008

Vulvar cancer is a rare gynecologic malignancy.Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)-dependent and HPV-independent pathways. The NCCN Vulvar Cancer panel is an interdisciplinary group of representatives from NCCN Member Institutions consisting of specialists in gynecological oncology, medical oncology, radiation oncology, and pathology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Vulvar Cancer provide an evidence- and consensus-based approach for the management of patients with vulvar SCC. This manuscript discusses the recommendations outlined in the NCCN Guidelines for diagnosis, staging, treatment, and follow-up.

• 单位
  西北大学